Cyclic n,n'-diarylthiourea - androgen receptor antagonist, anti breast cancer composition and use thereof
OwnerAlexandre Vasilievich IVACHTCHENKO, Oleg Dmitrievich MITKINinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerAlexandre Vasilievich IVACHTCHENKO, Oleg Dmitrievich MITKINinventors
Estimating the term…
The present invention relates to novel cyclic N,N′-diarylurea-androgen receptor antagonist, anti-cancer agent, pharmaceutical composition, medicament, and method for treatment of breast cancer disease. Cyclic N,N′-diarylthioureas or N,N′-diarylureas of the general formula 1, their optical (R)- and (S)-isomers and pharmaceutically acceptable salts thereof exhibiting properties of androgen receptor antagonists have been proposed, wherein: R1 represents C1-C3 alkyl; R4 and R5 represent hydrogen; or R4 represents hydrogen, R5 represents methyl; or R4 represents methyl, R5 represents CH2R6 group in which R6 is C1-C3 alkoxycarbonyl, carboxyl, hydroxyl group optionally substituted with methyl or benzyl; or R4 and R5 together with the carbon atom they are attached to form 5- or 6-membered saturated heterocycle including at least one oxygen atom or nitrogen atom optionally substituted with methyl.
A pharmaceutical composition for treating breast cancer comprising an effective amount of at least one cyclic N,N′-diarylthiourea compound of general formula 1.2, or an optical (R)- or (S)-isomer, or a pharmaceutically acceptable salt thereof, and further comprising a pharmaceutically acceptable carrier or an excipient,
Dependencies are inferred from the claim text.